Pradaxa.ie

For Republic of Ireland healthcare
professionals only

For primary prevention of venous thromboembolic events (VTE) in adult patients who have
undergone elective total hip or knee replacement surgery^1,2

Educational Pack

Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery^1,2

Report adverse events

Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie/homepage/about-us/report-an-issue.

Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 1850 946100.

Adverse Events

Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie/homepage/about-us/report-an-issue.

Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 1850 946100.

References:

Boehringer Ingelheim. Pradaxa^® 110mg hard capsules Summary of Product Characteristics.
Boehringer Ingelheim. Pradaxa^® 75mg hard capsules Summary of Product Characteristics.